NCT00720499 · Interventional trial
Efficacy and Safety of 4 Weeks of Treatment With Orally Inhaled BI1744/Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Overall registry status Completed
Phase 2
Conditions Pulmonary Disease, Chronic Obstructive
Delaware Valley sites
- 1237.9.00151 Boehringer Ingelheim Investigational Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory